PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27469405-4	2016	Moreover, treatment with dinaciclib led to the inhibition of oncogenic pathways normally activated in stimulated CLL cells, such as STAT3, NF-kappaB, p38, PI3K/AKT and RAF/MEK/ERK.	dinaciclib	25-35	mitogen-activated protein kinase 14	Homo sapiens	150-153